Company Overview of Redbiotec AG
Redbiotec AG develops and produces multiprotein assemblies. It specializes in producing virus-like particles (VLP), various types of protein complexes and single proteins, and VLP-based vaccines against various infectious diseases. The company’s products are used in complex drug target, structural studies, target validation, antibody generation, biopharmaceutical, and VLP applications. Redbiotec AG was founded in 2006 and is based in Schlieren, Switzerland.
Founded in 2006
41 44 200 23 20
41 44 200 23 21
Key Executives for Redbiotec AG
Redbiotec AG Key Developments
Similar Private Companies By Industry
|Delenex Therapeutics AG||Europe|
|SDK BioTechnologies AG||Europe|
Recent Private Companies Transactions
January 5, 2015
To contact Redbiotec AG, please visit www.redbiotec.ch. Company data is provided by Capital IQ. Please use this form to report any data issues.